An experimental drug for women revives an intense debate. In the coming days, the Food and Drug Administration will decide whether to approve an injection meant to increase women’s drive for sex. Its demonstrated effects are modest, but some doctors say the drug would meet a real need for thousands of women

Quick Read

This Pharma Exec Is Accused Of Fixing Prices On 107 Drugs

Quick Read

After eight heart attacks, a young wife and mother with an uncommon condition curates her legacy while decorating a new home

Quick Read

A Pennsylvania case illustrates a national problem: People with psychiatric illnesses often remain incarcerated while they wait for a hospital bed

Quick Read

Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding

Quick Read

A panel of government-appointed experts in Germany agreed unanimously that the human germline “is not inviolable,” rejecting one objection to using genome editing technologies such as CRISPR to make heritable changes in the DNA of human embryos, sperm, or eggs

Quick Read

“2019 is the year when the training wheels come off and the world gets to see what CRISPR can really do for the world in the most positive sense,” says Fyodor Urnov, a gene-editing scientist at the Altius Institute for Biomedical Sciences in Seattle and the University of California, Berkeley

Quick Read

“It’s easy to get on your high horse when you’re not in our position,” she said. “If editing an IVF embryo is the best option to mitigate the pain that a child would otherwise suffer, then give us the choice.”

Quick Read